中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2012年
22期
100-101
,共2页
中风不语症%中药治疗%解语丹%疗效观察
中風不語癥%中藥治療%解語丹%療效觀察
중풍불어증%중약치료%해어단%료효관찰
Stroke in silence%TCM treatment%Jieyu Dan%Efficacy observation
目的:观察解语丹在治疗中风不语症的临床效果.方法:将本组的60例入选病例随机分为治疗组30例和对照组30例.对照组的治疗以常规临床对症处理,治疗组在常规对症处理的基础上予以汤剂解语丹加减内服,对照组和治疗组的治疗期为4周,观察治疗前后患者语言表达的效果.结果:治疗组中有12例患者恢复语言功能,有效16例,2例无效,总有效率为93.33%;对照组有9例患者恢复语言功能,有效12例,无效9例,总有效率为70%;两组综合疗效医学统计比较,差异有显著性;患者均未发现明显的毒副反应.结论:解语丹配合常规对症处理治疗中风不语症疗效优于常规对症处理,且安全副作用少,是治疗中风后失语症的首选药物,并值得深入研究.
目的:觀察解語丹在治療中風不語癥的臨床效果.方法:將本組的60例入選病例隨機分為治療組30例和對照組30例.對照組的治療以常規臨床對癥處理,治療組在常規對癥處理的基礎上予以湯劑解語丹加減內服,對照組和治療組的治療期為4週,觀察治療前後患者語言錶達的效果.結果:治療組中有12例患者恢複語言功能,有效16例,2例無效,總有效率為93.33%;對照組有9例患者恢複語言功能,有效12例,無效9例,總有效率為70%;兩組綜閤療效醫學統計比較,差異有顯著性;患者均未髮現明顯的毒副反應.結論:解語丹配閤常規對癥處理治療中風不語癥療效優于常規對癥處理,且安全副作用少,是治療中風後失語癥的首選藥物,併值得深入研究.
목적:관찰해어단재치료중풍불어증적림상효과.방법:장본조적60례입선병례수궤분위치료조30례화대조조30례.대조조적치료이상규림상대증처리,치료조재상규대증처리적기출상여이탕제해어단가감내복,대조조화치료조적치료기위4주,관찰치료전후환자어언표체적효과.결과:치료조중유12례환자회복어언공능,유효16례,2례무효,총유효솔위93.33%;대조조유9례환자회복어언공능,유효12례,무효9례,총유효솔위70%;량조종합료효의학통계비교,차이유현저성;환자균미발현명현적독부반응.결론:해어단배합상규대증처리치료중풍불어증료효우우상규대증처리,차안전부작용소,시치료중풍후실어증적수선약물,병치득심입연구.
Objective: To observe the clinical effect of treating stroke in silence with the Jieyu Dan. Methods: 60 patients were randomly divided into the treatment group and the control group, 30 each. The control group therapy to routine clinical symptomatic treatment, the treatment group on the basis of conventional symptomatic treatment, was given the Jieyu Dan for treatment, the control group and the treatment group treatment period of 4 weeks, to observe the effect of the language expression of the patients before and after treatment. Results: In the treatment group, 12 patients restored language features, effective in 16 cases, 2 cases were ineffective, the total effective rate was 93.33%; and in the control group, 9 patients recovered language function, effective in 12 cases, the total effective rate was 70%; two groups efficacy of medical statistics comparing the difference was statistically significant; were not found in patients with significant toxicity. Conclusion: The Jieyu Dan symptomatic plus conventional treating stroke mutism effective than conventional symptomatic treatment and less side effects and safety, is the drug of choice for treating stroke aphasia, and worthy of further study.